News

Bristol Myers Squibb announced results for the co-primary endpoint for CheckMate -915, a randomized Phase 3 study evaluating Opdivo (nivolumab) plus Yervoy (ipilimumab) versus Opdivo for patients who have had a complete surgical removal of stage IIIb/c/d or stage...

EMA’s human medicines committee (CHMP) has started the first ‘rolling review’ of a COVID-19 vaccine, which is being developed by the company AstraZeneca in collaboration with the University of Oxford. The start of the rolling review means that the committee...

The Phase I/II clinical trial for the COVID-19 vaccine AZD1222 has resumed in Japan after discussion with the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). A standard review process triggered a voluntary pause to vaccination across all global trials on...

BIAL, a pharmaceutical company based in Portugal with locations across Europe and dedicated to R&D in CNS diseases, announced that it has established a new affiliate in the United States of America, BIAL Biotech Investments Inc. (BIAL Biotech). This...

Dr. Reddy’s Laboratories Ltd. announced the launch of Cinacalcet Tablets, a therapeutic equivalent generic version of Sensipar (cinacalcet) Tablets, approved by the U.S. Food and Drug Administration (USFDA). The Sensipar brand and generic market had U.S. sales of approximately $312...

Since the in-person PACK EXPO International and Healthcare Packaging EXPO have been cancelled, the process and packaging technology specialist Syntegon is presenting its latest solutions at the virtually-hosted PACK EXPO Connects from November 9 to 13, 2020. In a...

The Academic Medical Center (AZP) in Paramaribo, Suriname, successfully studied an efficient method to collect COVID-19 antibody-containing plasma from recovered Covid-19 patients to treat critically ill patients. In contrast with prevailing plasma donation strategies, the Academic Medical Center collects...